Summary
McKesson Corporation (MCK) filed an 8-K on December 10, 2012, to disclose a regulatory development concerning its proposed acquisition of PSS World Medical, Inc. The company, along with PSS World Medical, issued a joint press release indicating that McKesson has voluntarily withdrawn and re-filed its notification and report form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. This action is a procedural step often taken to address inquiries or concerns from antitrust regulators, potentially to allow for further review and facilitate the approval process. This filing is important for investors as it signals potential delays or continued scrutiny in the acquisition process of PSS World Medical. While the re-filing itself does not inherently mean the deal is in jeopardy, it suggests that regulatory authorities are actively reviewing the transaction. Investors should monitor subsequent filings and announcements for updates on the antitrust review and the expected closing date of the acquisition.
Key Highlights
- 1McKesson (MCK) announced a procedural update regarding its acquisition of PSS World Medical, Inc.
- 2McKesson voluntarily withdrew and re-filed its Hart-Scott-Rodino Act notification.
- 3This action is related to the ongoing antitrust review of the proposed acquisition.
- 4The filing includes a joint press release from McKesson and PSS World Medical dated December 10, 2012.
- 5The information is furnished under Regulation FD and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- 6Investors should closely monitor further developments in the antitrust review process.